These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
608 related items for PubMed ID: 21851213
1. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents. Alafeefy AM, Ashour AE. J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213 [Abstract] [Full Text] [Related]
2. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing. Alafeefy AM, Alqasoumi SI, Ashour AE, Alshebly MM. J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752 [Abstract] [Full Text] [Related]
3. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study. El-Azab AS, Al-Omar MA, Abdel-Aziz AA, Abdel-Aziz NI, el-Sayed MA, Aleisa AM, Sayed-Ahmed MM, Abdel-Hamide SG. Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299 [Abstract] [Full Text] [Related]
4. Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing. Alafeefy AM, Alqasoumi SI, Ashour AE, Masand V, Al-Jaber NA, Ben Hadda T, Mohamed MA. Eur J Med Chem; 2012 Jul; 53():133-40. PubMed ID: 22520152 [Abstract] [Full Text] [Related]
5. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent. Noolvi MN, Patel HM, Bhardwaj V, Chauhan A. Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891 [Abstract] [Full Text] [Related]
7. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety. He J, Wang X, Zhao X, Liang Y, He H, Fu L. Eur J Med Chem; 2012 Aug; 54():925-30. PubMed ID: 22749192 [Abstract] [Full Text] [Related]
8. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents. Alanazi AM, Abdel-Aziz AA, Al-Suwaidan IA, Abdel-Hamide SG, Shawer TZ, El-Azab AS. Eur J Med Chem; 2014 May 22; 79():446-54. PubMed ID: 24763265 [Abstract] [Full Text] [Related]
9. Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline. Cao SL, Han Y, Yuan CZ, Wang Y, Xiahou ZK, Liao J, Gao RT, Mao BB, Zhao BL, Li ZF, Xu X. Eur J Med Chem; 2013 Jun 22; 64():401-9. PubMed ID: 23665106 [Abstract] [Full Text] [Related]
10. Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors. Li DD, Fang F, Li JR, Du QR, Sun J, Gong HB, Zhu HL. Bioorg Med Chem Lett; 2012 Sep 15; 22(18):5870-5. PubMed ID: 22901387 [Abstract] [Full Text] [Related]
11. Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents. Luo H, Yang S, Cai Y, Peng Z, Liu T. Eur J Med Chem; 2014 Sep 12; 84():746-52. PubMed ID: 25064351 [Abstract] [Full Text] [Related]
12. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors. Rao GW, Xu GJ, Wang J, Jiang XL, Li HB. ChemMedChem; 2013 Jun 12; 8(6):928-33. PubMed ID: 23640754 [Abstract] [Full Text] [Related]
13. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties. Conconi MT, Marzaro G, Urbani L, Zanusso I, Di Liddo R, Castagliuolo I, Brun P, Tonus F, Ferrarese A, Guiotto A, Chilin A. Eur J Med Chem; 2013 Sep 12; 67():373-83. PubMed ID: 23900004 [Abstract] [Full Text] [Related]
14. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives. Lan P, Wang J, Zhang DM, Shu C, Cao HH, Sun PH, Wu XM, Ye WC, Chen WM. Eur J Med Chem; 2011 Jun 12; 46(6):2490-502. PubMed ID: 21496972 [Abstract] [Full Text] [Related]
15. Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines. Chandrika PM, Yakaiah T, Rao AR, Narsaiah B, Reddy NC, Sridhar V, Rao JV. Eur J Med Chem; 2008 Apr 12; 43(4):846-52. PubMed ID: 17689837 [Abstract] [Full Text] [Related]
16. Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2. Lu L, Zhao TT, Liu TB, Sun WX, Xu C, Li DD, Zhu HL. Chem Pharm Bull (Tokyo); 2016 Nov 01; 64(11):1570-1575. PubMed ID: 27568484 [Abstract] [Full Text] [Related]
18. Exploring epidermal growth factor receptor (EGFR) inhibitor features: the role of fused dioxygenated rings on the quinazoline scaffold. Chilin A, Conconi MT, Marzaro G, Guiotto A, Urbani L, Tonus F, Parnigotto P. J Med Chem; 2010 Feb 25; 53(4):1862-6. PubMed ID: 20095624 [Abstract] [Full Text] [Related]
19. Use of Quantitative Structure-Activity Relationship (QSAR) and ADMET prediction studies as screening methods for design of benzyl urea derivatives for anti-cancer activity. Lokwani D, Bhandari S, Pujari R, Shastri P, Shelke G, Pawar V. J Enzyme Inhib Med Chem; 2011 Jun 25; 26(3):319-31. PubMed ID: 20846089 [Abstract] [Full Text] [Related]
20. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs. Al-Obaid AM, Abdel-Hamide SG, El-Kashef HA, Abdel-Aziz AA, El-Azab AS, Al-Khamees HA, El-Subbagh HI. Eur J Med Chem; 2009 Jun 25; 44(6):2379-91. PubMed ID: 18950904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]